SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 195.72 |
| Enterprise Value ($M) | 196.35 |
| Book Value ($M) | 3.44 |
| Book Value / Share | 0.12 |
| Price / Book | 56.93 |
| NCAV ($M) | -0.90 |
| NCAV / Share | -0.03 |
| Price / NCAV | -217.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.21 |
| Return on Assets (ROA) | -268.25 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.33 |
| Current Ratio | 0.33 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.44 |
| Assets | 4.77 |
| Liabilities | 1.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -3.94 |
| Net Income | -13.07 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.86 |
| Cash from Investing | 0.00 |
| Cash from Financing | 3.86 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 427 | 3,578 | 11.93 | |
| 834 | 686 | 121.57 | |
| 1,537 | 882 | 174.26 | |
| 3,397 | 2,947 | 115.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SYBX – Synlogic, Inc. | TCON – TRACON Pharmaceuticals, Inc. |
| TCRT – Alaunos Therapeutics, Inc. | TENX – Tenax Therapeutics, Inc. |
| TFFP – TFF Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io